Polymyalgia rheumatica

G Espígol-Frigolé, C Dejaco, SL Mackie, C Salvarani… - The Lancet, 2023 - thelancet.com
Polymyalgia rheumatica is an inflammatory disease producing pain and stiffness, mainly in
the shoulders and pelvic girdle, in people older than 50 years. Elevation of acute phase …

Imaging for large-vessel vasculitis

D Blockmans, T Bley, W Schmidt - Current opinion in …, 2009 - journals.lww.com
Imaging for large-vessel vasculitis : Current Opinion in Rheumatology Imaging for large-vessel
vasculitis : Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe …

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative …

B Dasgupta, MA Cimmino, HM Kremers… - Arthritis & …, 2012 - Wiley Online Library
The objective of this study was to develop European League Against Rheumatism/American
College of Rheumatology classification criteria for polymyalgia rheumatica (PMR) …

BSR and BHPR guidelines for the management of polymyalgia rheumatica

B Dasgupta, FA Borg, N Hassan, K Barraclough… - …, 2010 - academic.oup.com
Raman spectroscopy was used for the first time to detect the effect of independent UVA
(ultraviolet-A: 320–400 nm) and UVB (ultraviolet-B: 280–320 nm) irradiation on the calf …

Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study

V Devauchelle-Pensec, JM Berthelot… - Annals of the …, 2016 - ard.bmj.com
Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR)
but induce adverse events. Objectives To evaluate the efficacy and safety of first-line …

Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia …

KK Keller, CB Mukhtyar, AW Nielsen… - Annals of the …, 2023 - ard.bmj.com
Objective To develop international consensus-based recommendations for early referral of
individuals with suspected polymyalgia rheumatica (PMR). Methods A task force including …

Efficacy and tolerability of leflunomide in difficult‐to‐treat polymyalgia rheumatica and giant cell arteritis: a case series

T Adizie, D Christidis, C Dharmapaliah… - … journal of clinical …, 2012 - Wiley Online Library
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related inflammatory
rheumatic conditions affecting adults over the age of 50 years. Both conditions respond to …

Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial

A Saraux, C Le Henaff, E Dernis… - The Lancet …, 2023 - thelancet.com
Background Medium-dose glucocorticoids can improve symptoms in nearly all patients with
polymyalgia rheumatica. According to its good safety profile, abatacept could be used …

Treatment of polymyalgia rheumatica: a systematic review

J Hernandez-Rodriguez, MC Cid… - Archives of Internal …, 2009 - jamanetwork.com
Background Polymyalgia rheumatica (PMR) treatment is based on low-dose glucocorticoids.
Glucocorticoid-sparing agents have also been tested. Our objective was to systematically …

Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus

C Dejaco, C Duftner, MA Cimmino… - Annals of the …, 2011 - ard.bmj.com
Objective To compare current definitions of remission and relapse in polymyalgia
rheumatica (PMR) with items resulting from a Delphi-based expert consensus. Methods …